TipRanks
Go Ultimate75% OFF

Asia Medical and Agricultural Laboratory and Research Center PCL (AMARC) Stock Statistics & Valuation Metrics

Total Valuation

Asia Medical and Agricultural Laboratory and Research Center PCL has a market cap or net worth of THB 1.15B. The enterprise value is THB 1.26B.

Market Cap
THB 1.15B
Enterprise Value
THB 1.26B

Share Statistics

Asia Medical and Agricultural Laboratory and Research Center PCL has 420,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
420,000,000
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Asia Medical and Agricultural Laboratory and Research Center PCL’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 22.96%.

Return on Equity (ROE)
0.26
Return on Assets (ROA)
0.22
Return on Invested Capital (ROIC)
22.96%
Return on Capital Employed (ROCE)
0.23
Revenue Per Employee
2.22M
Profits Per Employee
717.47K
Employee Count
221
Asset Turnover
0.69
Inventory Turnover
17.64

Valuation Ratios

The current PE Ratio of Asia Medical and Agricultural Laboratory and Research Center PCL is 9.09. Asia Medical and Agricultural Laboratory and Research Center PCL’s PEG ratio is 0.09.

PE Ratio
9.09
PS Ratio
2.41
PB Ratio
1.94
Price to FCF
11.23
Price to Operating Cash Flow
7.82
PEG Ratio
0.09

Income Statement

In the last 12 months, Asia Medical and Agricultural Laboratory and Research Center PCL had revenue of 491.01M and earned 158.56M in profits. Earnings per share was 0.38.

Revenue
491.01M
Gross Profit
265.29M
Operating Income
154.62M
Pretax Income
157.31M
Net Income
158.56M
EBITDA
196.13M
Earnings Per Share (EPS)
0.38

Cash Flow

In the last 12 months, operating cash flow was 145.11M and capital expenditures -45.97M, giving a free cash flow of 99.15M billion.

Operating Cash Flow
145.11M
Free Cash Flow
99.15M
Free Cash Flow per Share
0.24

Dividends & Yields

Asia Medical and Agricultural Laboratory and Research Center PCL pays an annual dividend of ―, resulting in a dividend yield of 9.12%

Dividend Per Share
―
Dividend Yield
9.12%
Payout Ratio
N/A
Free Cash Flow Yield
8.91%
Earnings Yield
11.20%

Stock Price Statistics

Beta
1.19
52-Week Price Change
-7.43%
50-Day Moving Average
―
200-Day Moving Average
―
Relative Strength Index (RSI)
33.06
Average Volume (3m)
1.12M

Important Dates

Asia Medical and Agricultural Laboratory and Research Center PCL upcoming earnings date is Nov 11, 2026, TBA (Not Confirmed).

Last Earnings Date
Aug 11, 2026
Next Earnings Date
Nov 11, 2026
Ex-Dividend Date
―

Financial Position

Asia Medical and Agricultural Laboratory and Research Center PCL as a current ratio of 4.78, with Debt / Equity ratio of 3.49%

Current Ratio
4.78
Quick Ratio
4.55
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.13
Interest Coverage Ratio
161.52

Taxes

In the past 12 months, Asia Medical and Agricultural Laboratory and Research Center PCL has paid -1.25M in taxes.

Income Tax
-1.25M
Effective Tax Rate
-0.01

Enterprise Valuation

Asia Medical and Agricultural Laboratory and Research Center PCL EV to EBITDA ratio is 5.99, with an EV/FCF ratio of 10.03.

EV to Sales
2.15
EV to EBITDA
5.99
EV to Free Cash Flow
10.03
EV to Operating Cash Flow
6.85

Balance Sheet

Asia Medical and Agricultural Laboratory and Research Center PCL has THB 144.18M in cash and marketable securities with THB 24.86M in debt, giving a net cash position of THB 119.32M billion.

Cash & Marketable Securities
THB 144.18M
Total Debt
THB 24.86M
Net Cash
THB 119.32M
Net Cash Per Share
THB 0.28
Tangible Book Value Per Share
THB 1.36

Margins

Gross margin is 50.27%, with operating margin of 26.78%, and net profit margin of 27.48%.

Gross Margin
50.27%
Operating Margin
26.78%
Pretax Margin
27.01%
Net Profit Margin
27.48%
EBITDA Margin
35.88%
EBIT Margin
26.78%

Analyst Forecast

The average price target for Asia Medical and Agricultural Laboratory and Research Center PCL is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
1.73%
EPS Growth Forecast
1.03%